Home › Funds › Evelyn Partners Investment Management (Europe) Ltd › GEHC

Evelyn Partners Investment Management (Europe) Ltd position in GEHC

GE HEALTHCARE TECHNOLOGIES I · Health Care

Evelyn Partners Investment Management (Europe) Ltd reported holding 11,039 shares of GEHC (GE HEALTHCARE TECHNOLOGIES I) in its Q1 2026 13F filing — a position valued at US$786K, representing 0.27% of its reported portfolio and ranking #48 among its reported holdings. Evelyn Partners Investment Management (Europe) Ltd has disclosed GEHC holdings in 6 of the last 6 reported quarters, going back to Q4 2024.

Latest position (Q1 2026)11.04K sh
Reported value held$785.76K
Portfolio Weight0.27%
First reportedQ4 2024
Last changeReduce
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How Evelyn Partners Investment Management (Europe) Ltd's GEHC position evolved

Evelyn Partners Investment Management (Europe) Ltd first disclosed a stake in GEHC in Q4 2024 at 12,286 shares (US$961K). The position peaked in Q1 2025 at 16,432 shares, worth US$1.3M. Across 6 filings, Evelyn Partners Investment Management (Europe) Ltd increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 11,039 shares valued at US$786K — a reduction of -4,074 shares quarter over quarter.. Notable position changes include a 34% increase in Q1 2025 (shares fell 9% over the following quarter), a 27% trim in Q1 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 12.29K $960.52K New
Q1 2025 16.43K $1.33M Add
Q2 2025 14.08K $1.04M Reduce
Q3 2025 12.84K $964.13K Reduce
Q4 2025 15.11K $1.24M Add
Q1 2026 11.04K $785.76K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GEHC and 13F data

GEHC (GE HEALTHCARE TECHNOLOGIES I) is a Health Care company. 27 other funds we track also report a position in GEHC — the largest reported positions include Dodge & Cox (US$2.42B), DODGE & COX (US$2.42B), Harris Associates (Oakmark) (US$981.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GEHC

All GEHC fund holders →

FAQ

How long has Evelyn Partners Investment Management (Europe) Ltd held GEHC?

Evelyn Partners Investment Management (Europe) Ltd has disclosed GEHC holdings in 6 of the last 6 reported quarters, going back to Q4 2024.

What is Evelyn Partners Investment Management (Europe) Ltd's current position in GEHC?

As of Q1 2026, Evelyn Partners Investment Management (Europe) Ltd holds 11.04K shares of GEHC (GE HEALTHCARE TECHNOLOGIES I), valued at $785.76K, representing 0.27% of its reported portfolio and ranking #48.

Has Evelyn Partners Investment Management (Europe) Ltd been buying or selling GEHC?

In the latest 13F filing (Q1 2026), Evelyn Partners Investment Management (Europe) Ltd reduced its position in GEHC. The position peaked in Q1 2025 at 16.43K shares.

Which other funds hold GEHC?

Other major institutional holders of GEHC include Dodge & Cox, DODGE & COX, Harris Associates (Oakmark), among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.